Clinical Roundup CAP publishes guideline for PD-L1 testing for lung cancer April 19, 2024Vol.50 No.16
Clinical Roundup Urine test improves non-invasive detection of prostate cancer April 19, 2024Vol.50 No.16
Clinical Roundup Clinical tool predicts immunotherapy response in uveal melanoma patients April 19, 2024Vol.50 No.16
Clinical Roundup Subgroup analysis focuses on P-BCMA-ALLO1 allogeneic CAR T in multiple myeloma April 19, 2024Vol.50 No.16
Drugs & Targets FDA approves Alecensa for ALK-positive early-stage lung cancer April 19, 2024Vol.50 No.16
Drugs & Targets MD Anderson and CureVac collaborate to develop mRNA cancer vaccines April 19, 2024Vol.50 No.16
Drugs & Targets COTA and Sanofi collaborate to accelerate cancer trials using real-world data and AI April 19, 2024Vol.50 No.16
NCI Rathmell: To improve funding outlook, we must reverse distrust in science April 12, 2024Vol.50 No.15By Matthew Bin Han Ong
